Germany

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents

Tuesday, May 11, 2021 - 2:02am

This is the first COVID-19 vaccine authorized in the U.S. for use in this age group.\nThis press release features multimedia.

Key Points: 
  • This is the first COVID-19 vaccine authorized in the U.S. for use in this age group.\nThis press release features multimedia.
  • \xe2\x80\x9cWe are grateful to all of our clinical trial volunteers and their families, whose courage helped make this milestone possible.
  • Topline results from this trial, announced on March 31, 2021, showed a vaccine efficacy of 100% in participants with or without prior SARS-CoV-2 infection and robust antibody responses.
  • \xe2\x80\x9cOur work is not yet complete, as we continue our research into the use of our vaccine in pediatric populations.

ZEISS to acquire Capture 3D to extend its industry expertise in 3D measurement and inspection solutions

Monday, May 10, 2021 - 11:32pm

Headquartered in Santa Ana, California, Capture 3D is the leading US partner for GOM 3D non-contact measuring solutions.

Key Points: 
  • Headquartered in Santa Ana, California, Capture 3D is the leading US partner for GOM 3D non-contact measuring solutions.
  • "Being part of the ZEISS Family will open up new opportunities for the Capture 3D team and our customers in the future.
  • "\n"Having such a talented team with expert industry knowledge and a passion for 3D metrology is important," states Michael Kirchner, Head of ZEISS Industrial Quality Solutions in the US.
  • In addition, ZEISS Industrial Quality Solutions offers a broad global spectrum of customer services with ZEISS Quality Excellence Centers close to its customers.

ZEISS to Acquire Capture 3D to Extend Its Industry Expertise in 3D Measurement and Inspection Solutions

Monday, May 10, 2021 - 10:00pm

Headquartered in Santa Ana, California, Capture 3D is the leading US partner for GOM 3D non-contact measuring solutions.

Key Points: 
  • Headquartered in Santa Ana, California, Capture 3D is the leading US partner for GOM 3D non-contact measuring solutions.
  • "Being part of the ZEISS Family will open up new opportunities for the Capture 3D team and our customers in the future.
  • "\n\xe2\x80\x9cHaving such a talented team with expert industry knowledge and a passion for 3D metrology is important,\xe2\x80\x9d states Michael Kirchner, Head of ZEISS Industrial Quality Solutions in the US.
  • Capture 3D combines vast industry expertise with robust technology to change the way people think about and experience measurement.\n'

Nayax Announces the Pricing of its Initial Public Offering

Monday, May 10, 2021 - 6:30pm

b'HERZLIYA, Israel, May 10, 2021 /PRNewswire/ -- Nayax Ltd. ("Nayax") announced today the pricing of itsglobal initial public offering of 63,500,000 ordinary shares at a price per share of ILS 10.50 (approx.

Key Points: 
  • b'HERZLIYA, Israel, May 10, 2021 /PRNewswire/ -- Nayax Ltd. ("Nayax") announced today the pricing of itsglobal initial public offering of 63,500,000 ordinary shares at a price per share of ILS 10.50 (approx.
  • The offering comprises 44,000,000 ordinary shares by Nayax and an aggregate of 19,500,000 ordinary shares by three existing shareholders (the "Selling Shareholders").
  • In addition, Nayax has granted the underwriters a 30-day option to purchase up to an additional 9,525,000 ordinary shares from Nayax, at the initial public offering price.
  • Said forward-looking statements, relating to the initial public offering, are subject to uncertainties and assumptions and the actual results may materially differ.

Nayax Announces the Pricing of its Initial Public Offering

Monday, May 10, 2021 - 6:26pm

b'HERZLIYA, Israel, May 10, 2021 /PRNewswire/ -- Nayax Ltd. ("Nayax") announced today the pricing of itsglobal initial public offering of 63,500,000 ordinary shares at a price per share of ILS 10.50 (approx.

Key Points: 
  • b'HERZLIYA, Israel, May 10, 2021 /PRNewswire/ -- Nayax Ltd. ("Nayax") announced today the pricing of itsglobal initial public offering of 63,500,000 ordinary shares at a price per share of ILS 10.50 (approx.
  • The offering comprises 44,000,000 ordinary shares by Nayax and an aggregate of 19,500,000 ordinary shares by three existing shareholders (the "Selling Shareholders").
  • In addition, Nayax has granted the underwriters a 30-day option to purchase up to an additional 9,525,000 ordinary shares from Nayax, at the initial public offering price.
  • Said forward-looking statements, relating to the initial public offering, are subject to uncertainties and assumptions and the actual results may materially differ.

NOXXON Announces Data Safety Monitoring Board Validates NOX-A12 Highest Dose in Phase 1/2 Brain Cancer Trial

Monday, May 10, 2021 - 5:00pm

NOXXON is also studying NOX-A12 in brain cancer in combination with radiotherapy which has been granted orphan drug status in the US and EU for the treatment of certain brain cancers.

Key Points: 
  • NOXXON is also studying NOX-A12 in brain cancer in combination with radiotherapy which has been granted orphan drug status in the US and EU for the treatment of certain brain cancers.
  • A trial of NOX-A12 in combination with radiotherapy in newly diagnosed brain cancer patients who will not benefit from standard chemotherapy has delivered preliminary data from the first cohort showing consistent tumor reductions.
  • The company\xe2\x80\x99s second clinical-stage asset NOX-E36 is a Phase 2 TME asset targeting the innate immune system.
  • NOXXON plans to test NOX\xe2\x80\x91E36 in patients with solid tumors both as a monotherapy and in combination.

deCODE genetics - Rounding off the human genome

Monday, May 10, 2021 - 4:00pm

However of 133,886 reliably genotyped structural variants detected with long-read sequencing only 60% can be detected with short-reads.\nUsing PromethION sequencers from Oxford Nanopore Technologies, researchers at deCODE genetics whole genome sequenced 3,622 Icelanders.

Key Points: 
  • However of 133,886 reliably genotyped structural variants detected with long-read sequencing only 60% can be detected with short-reads.\nUsing PromethION sequencers from Oxford Nanopore Technologies, researchers at deCODE genetics whole genome sequenced 3,622 Icelanders.
  • These variants were then imputed into a larger set of participants in various disease studies at deCODE genetics and associated with phenotypes.
  • This is a major stumbling block in the attempt to fully understand the relationship between variation in the sequence of the human genome and human diversity.
  • Using its unique expertise and population resources, deCODE has discovered genetic risk factors for dozens of common diseases.

deCODE genetics - Rounding off the human genome

Monday, May 10, 2021 - 4:00pm

However of 133,886 reliably genotyped structural variants detected with long-read sequencing only 60% can be detected with short-reads.\nUsing PromethION sequencers from Oxford Nanopore Technologies, researchers at deCODE genetics whole genome sequenced 3,622 Icelanders.

Key Points: 
  • However of 133,886 reliably genotyped structural variants detected with long-read sequencing only 60% can be detected with short-reads.\nUsing PromethION sequencers from Oxford Nanopore Technologies, researchers at deCODE genetics whole genome sequenced 3,622 Icelanders.
  • These variants were then imputed into a larger set of participants in various disease studies at deCODE genetics and associated with phenotypes.
  • This is a major stumbling block in the attempt to fully understand the relationship between variation in the sequence of the human genome and human diversity.
  • Using its unique expertise and population resources, deCODE has discovered genetic risk factors for dozens of common diseases.

SmartBug is ready to launch

Monday, May 10, 2021 - 3:00pm

b'CATANIA, Italy, May 10, 2021 /PRNewswire/ --SmartBug is an Italian startup that is getting ready to globally launch its home automation ecosystem on Kickstarter.

Key Points: 
  • b'CATANIA, Italy, May 10, 2021 /PRNewswire/ --SmartBug is an Italian startup that is getting ready to globally launch its home automation ecosystem on Kickstarter.
  • SmartBug is a smart home system with which users can automate their home.
  • The mesh network allows for a link between the various SmartBugs, creating a network that requires no signal repeaters.
  • With SmartBug, the user can control the most traditional technology through an intelligent app that can be downloaded on the smartphone where it stores all codes, adding infinite potentials.

SmartBug is ready to launch

Monday, May 10, 2021 - 3:00pm

b'CATANIA, Italy, May 10, 2021 /PRNewswire/ --SmartBug is an Italian startup that is getting ready to globally launch its home automation ecosystem on Kickstarter.

Key Points: 
  • b'CATANIA, Italy, May 10, 2021 /PRNewswire/ --SmartBug is an Italian startup that is getting ready to globally launch its home automation ecosystem on Kickstarter.
  • SmartBug is a smart home system with which users can automate their home.
  • The mesh network allows for a link between the various SmartBugs, creating a network that requires no signal repeaters.
  • With SmartBug, the user can control the most traditional technology through an intelligent app that can be downloaded on the smartphone where it stores all codes, adding infinite potentials.